Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-11

FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Original Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved NorthStar RxLLC's generic nitrofurantoin monohydrate/macrocrystals (ANDA) for treating urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (monohydrate/macrocrystals) (Nitrofurantoin monohydrate/macrocystals)

Snippet

ORIG AP for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS))